Mechanisms of Spontaneous Resolution of Rat Liver Fibrosis. Hepatic Stellate Cell Apoptosis and Reduced Hepatic Expression of Metalloproteinase Inhibitors

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1998 Aug 6

PMID 9691091

Citations 332

Authors

J P Iredale

R C Benyon

J Pickering

M McCullen

M Northrop

S Pawley

C Hovell

M J Arthur

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.

Citing Articles

The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.

Da Silva K, Kumar P, Choonara Y Wound Repair Regen. 2025; 33(1):e13251.

PMID: 39780313 PMC: 11711308. DOI: 10.1111/wrr.13251.

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.

Activation of MEK-ERK-c-MYC signaling pathway promotes splenic M2-like macrophage polarization to inhibit PHcH-liver cirrhosis.

Guihu W, Wei D, Hailong Z, Chongyu Z, Jin S, Mengchen Z Front Immunol. 2024; 15:1417521.

PMID: 39620221 PMC: 11605246. DOI: 10.3389/fimmu.2024.1417521.

p53 and the E3 Ubiquitin Ligase MDM2 in Glaucomatous Lamina Cribrosa Cells.

McElhinney K, Irnaten M, OCallaghan J, OBrien C Int J Mol Sci. 2024; 25(22).

PMID: 39596239 PMC: 11595009. DOI: 10.3390/ijms252212173.

Time-course RNA sequencing reveals high similarity in mRNAome between hepatic stellate cells activated by agalactosyl IgG and TGF-β1.

Kao C, Ho C Funct Integr Genomics. 2024; 24(6):215.

PMID: 39549087 DOI: 10.1007/s10142-024-01502-z.

References

Iredale J, Murphy G, Hembry R, Friedman S, Arthur M . Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest. 1992; 90(1):282-7. PMC: 443094. DOI: 10.1172/JCI115850. View

Li J, Kim C, Leo M, Mak K, Rojkind M, Lieber C . Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes. Hepatology. 1992; 15(3):373-81. DOI: 10.1002/hep.1840150303. View

Fanidi A, Harrington E, Evan G . Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature. 1992; 359(6395):554-6. DOI: 10.1038/359554a0. View

Friedman S . Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993; 328(25):1828-35. DOI: 10.1056/NEJM199306243282508. View

Burt A . C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis. J Pathol. 1993; 170(2):105-14. DOI: 10.1002/path.1711700203. View

Muzzillo D, Imoto M, Fukuda Y, Koyama Y, Saga S, Nagai Y . Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gastroenterol Hepatol. 1993; 8(5):437-41. DOI: 10.1111/j.1440-1746.1993.tb01544.x. View

Murawaki Y, Yamamoto H, Kawasaki H, Shima H . Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma. Clin Chim Acta. 1993; 218(1):47-58. DOI: 10.1016/0009-8981(93)90221-o. View

Freije J, Diez-Itza I, Balbin M, Sanchez L, Blasco R, Tolivia J . Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem. 1994; 269(24):16766-73. View

Baker A, Mooney A, Hughes J, Lombardi D, Johnson R, Savill J . Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest. 1994; 94(5):2105-16. PMC: 294654. DOI: 10.1172/JCI117565. View

10.

Murawaki Y, Kawasaki H, Burkhardt H . Serum collagenase activity in chronic liver diseases. Pathol Res Pract. 1994; 190(9-10):929-33. DOI: 10.1016/S0344-0338(11)80998-2. View

11.

Patel T, Gores G . Apoptosis and hepatobiliary disease. Hepatology. 1995; 21(6):1725-41. DOI: 10.1002/hep.1840210635. View

12.

Iredale J, Goddard S, Murphy G, Benyon R, Arthur M . Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci (Lond). 1995; 89(1):75-81. DOI: 10.1042/cs0890075. View

13.

Evan G, Wyllie A, GILBERT C, Littlewood T, Land H, Brooks M . Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992; 69(1):119-28. DOI: 10.1016/0092-8674(92)90123-t. View

14.

Benyon R, Iredale J, Goddard S, Winwood P, Arthur M . Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 1996; 110(3):821-31. DOI: 10.1053/gast.1996.v110.pm8608892. View

15.

Evan G, Brown L, Whyte M, Harrington E . Apoptosis and the cell cycle. Curr Opin Cell Biol. 1995; 7(6):825-34. DOI: 10.1016/0955-0674(95)80066-2. View

16.

Vaux D, Strasser A . The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 1996; 93(6):2239-44. PMC: 39779. DOI: 10.1073/pnas.93.6.2239. View

17.

Fraser A, Evan G . A license to kill. Cell. 1996; 85(6):781-4. DOI: 10.1016/s0092-8674(00)81005-3. View

18.

Iredale J, Benyon R, Arthur M, Ferris W, Alcolado R, Winwood P . Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 1996; 24(1):176-84. DOI: 10.1002/hep.510240129. View

19.

De Bleser P, Niki T, Xu G, Rogiers V, Geerts A . Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology. 1997; 26(4):905-12. DOI: 10.1002/hep.510260416. View

20.

Saile B, Knittel T, Matthes N, Schott P, Ramadori G . CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol. 1997; 151(5):1265-72. PMC: 1858076. View